BEIJING (Reuters) – China’s drug safety body has found no problems in its inspection of 45 vaccine makers and will step up supervision of vaccine quality, it said on Friday, following a scandal that put children at risk.

The inspections were done between July 23 and Aug 9, the State Administration for Market Regulation said in a statement.

The statement comes after a public outcry over the discovery that Changsheng Bio-technology Co Ltd falsified data for a rabies vaccine and made an ineffective vaccine for babies. Beijing has promised to punish all those responsible and prevent a recurrence.

(Reporting by Beijing Monitoring Desk; Editing by Clarence Fernandez)